» Articles » PMID: 18559920

Fasting Plasma Glucose Cutoff for Diagnosis of Diabetes in a Japanese Population

Overview
Specialty Endocrinology
Date 2008 Jun 19
PMID 18559920
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We examined the relationship between fasting plasma glucose (FPG) and 2-h post-load glucose (PG) levels, and the optimal FPG cutoff level to correspond to a 2-h PG of 11.1 mmol/liter, the gold standard diagnostic criterion, in a general Japanese population.

Design: Cross-sectional study populations of 2421 subjects in 1988 and 2698 subjects in 2002, aged 40-79 yr and without antidiabetic medication, were tested with an oral glucose tolerance test. The relationship between FPG and 2-h PG was investigated by various regression models and a receiver operating characteristic curve.

Results: The best-fit model for the relationship between FPG and 2-h PG was a quadratic regression model. The FPG cutoff levels corresponding to the 2-h PG of 11.1 mmol/liter by this model were 6.2 mmol/liter in 1988 and 6.3 mmol/liter in 2002. In the combined populations, the FPG cutoff point was 6.3 mmol/liter; the sensitivity and specificity of this cutoff point for detecting a 2-h PG of 11.1 mmol/liter were 75.2 and 88.6%, respectively. The receiver operating characteristic curve analysis confirmed that the corresponding FPG point was 6.2 mmol/liter in both the 1988 and 2002 populations. In a stratified analysis, the FPG cutoff level increased with increasing body mass index levels; however, even in subjects with body mass index more than or equal to 30 kg/m2, the FPG cutoff level was lower than 7.0 mmol/liter.

Conclusions: Our findings suggest that the FPG cutoff level corresponding to the 2-h PG of 11.1 mmol/liter in the general Japanese population is lower than the current diagnostic criterion.

Citing Articles

Association of serum brain-derived neurotrophic factor with hepatic enzymes, AST/ALT ratio, and FIB-4 index in middle-aged and older women.

Yokokawa T, Sasaki S, Sase K, Yoshii N, Yasuda J, Hayashi T PLoS One. 2022; 17(8):e0273056.

PMID: 35998179 PMC: 9398011. DOI: 10.1371/journal.pone.0273056.


The Oral Glucose Tolerance Test: 100 Years Later.

Jagannathan R, Neves J, Dorcely B, Chung S, Tamura K, Rhee M Diabetes Metab Syndr Obes. 2020; 13:3787-3805.

PMID: 33116727 PMC: 7585270. DOI: 10.2147/DMSO.S246062.


Plasma glucose in screening for diabetes and pre-diabetes: how much is too much? Analysis of fasting plasma glucose and oral glucose tolerance test in Sri Lankans.

Katulanda G, Katulanda P, Dematapitiya C, Dissanayake H, Wijeratne S, Sheriff M BMC Endocr Disord. 2019; 19(1):11.

PMID: 30670002 PMC: 6341544. DOI: 10.1186/s12902-019-0343-x.


Management of Elevated Cholesterol in the primary prevention Group of Adult Japanese (MEGA) Study assists the view that a fasting plasma glucose level ≥100 mg/dL increases cardiovascular risk.

Tajima N, Kurata H, Ohashi Y, Mizuno K, Nakamura H J Diabetes Investig. 2014; 2(5):399-405.

PMID: 24843520 PMC: 4019309. DOI: 10.1111/j.2040-1124.2011.00121.x.


The construction of risk prediction models using GWAS data and its application to a type 2 diabetes prospective cohort.

Shigemizu D, Abe T, Morizono T, Johnson T, Boroevich K, Hirakawa Y PLoS One. 2014; 9(3):e92549.

PMID: 24651836 PMC: 3961382. DOI: 10.1371/journal.pone.0092549.